365 related articles for article (PubMed ID: 32970675)
1. Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae.
Rice CA; Colon BL; Chen E; Hull MV; Kyle DE
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008353. PubMed ID: 32970675
[TBL] [Abstract][Full Text] [Related]
2. Combined drug therapy in the management of granulomatous amoebic encephalitis due to Acanthamoeba spp., and Balamuthia mandrillaris.
Kulsoom H; Baig AM; Siddiqui R; Khan NA
Exp Parasitol; 2014 Nov; 145 Suppl():S115-20. PubMed ID: 24726699
[TBL] [Abstract][Full Text] [Related]
3. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri.
Schuster FL; Guglielmo BJ; Visvesvara GS
J Eukaryot Microbiol; 2006; 53(2):121-6. PubMed ID: 16579814
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Glucokinases from Pathogenic Free-Living Amoebae.
Milanes JE; Suryadi J; Monaghan NP; Harding EM; Morris CS; Rozema SD; Khalifa MM; Golden JE; Phan IQ; Zigweid R; Abendroth J; Rice CA; McCord HT; Wilson S; Fenwick MK; Morris JC
Antimicrob Agents Chemother; 2022 Jun; 66(6):e0237321. PubMed ID: 35604214
[TBL] [Abstract][Full Text] [Related]
5. Infections Caused by Free-Living Amoebae.
Kofman A; Guarner J
J Clin Microbiol; 2022 Jan; 60(1):e0022821. PubMed ID: 34133896
[TBL] [Abstract][Full Text] [Related]
6. "Proposals for Amendments in the Diagnosis and Treatment of Encephalitis caused by Free-living Amoebae".
Baig AM
Infect Disord Drug Targets; 2020; 20(2):115-121. PubMed ID: 30961516
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of amoebic encephalitis: Are the amoebae being credited to an 'inside job' done by the host immune response?
Baig AM
Acta Trop; 2015 Aug; 148():72-6. PubMed ID: 25930186
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Anti-Amoebic Inhibitors from Screening the MMV Pandemic Response Box on
Rice CA; Troth EV; Russell AC; Kyle DE
Pathogens; 2020 Jun; 9(6):. PubMed ID: 32560115
[TBL] [Abstract][Full Text] [Related]
9. Molecular identification of Acanthamoeba spp., Balamuthia mandrillaris and Naegleria fowleri in soil samples using quantitative real-time PCR assay in Turkey; Hidden danger in the soil!
Aykur M; Dagci H
Acta Trop; 2023 Aug; 244():106956. PubMed ID: 37244403
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic free-living amoebic encephalitis in Japan.
Hara T; Yagita K; Sugita Y
Neuropathology; 2019 Aug; 39(4):251-258. PubMed ID: 31243796
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic free-living amoebae: epidemiology and clinical review.
Trabelsi H; Dendana F; Sellami A; Sellami H; Cheikhrouhou F; Neji S; Makni F; Ayadi A
Pathol Biol (Paris); 2012 Dec; 60(6):399-405. PubMed ID: 22520593
[TBL] [Abstract][Full Text] [Related]
12. Opportunistic free-living amoebal pathogens.
Mungroo MR; Khan NA; Maciver S; Siddiqui R
Pathog Glob Health; 2022 Mar; 116(2):70-84. PubMed ID: 34602025
[TBL] [Abstract][Full Text] [Related]
13. Repositioning of Guanabenz in Conjugation with Gold and Silver Nanoparticles against Pathogenic Amoebae
Anwar A; Mungroo MR; Anwar A; Sullivan WJ; Khan NA; Siddiqui R
ACS Infect Dis; 2019 Dec; 5(12):2039-2046. PubMed ID: 31612700
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea.
Visvesvara GS; Moura H; Schuster FL
FEMS Immunol Med Microbiol; 2007 Jun; 50(1):1-26. PubMed ID: 17428307
[TBL] [Abstract][Full Text] [Related]
15. Opportunistic amoebae: challenges in prophylaxis and treatment.
Schuster FL; Visvesvara GS
Drug Resist Updat; 2004 Feb; 7(1):41-51. PubMed ID: 15072770
[TBL] [Abstract][Full Text] [Related]
16. Functional Assessment of 2,177 U.S. and International Drugs Identifies the Quinoline Nitroxoline as a Potent Amoebicidal Agent against the Pathogen
Laurie MT; White CV; Retallack H; Wu W; Moser MS; Sakanari JA; Ang K; Wilson C; Arkin MR; DeRisi JL
mBio; 2018 Oct; 9(5):. PubMed ID: 30377287
[No Abstract] [Full Text] [Related]
17. The transcriptome of Balamuthia mandrillaris trophozoites for structure-guided drug design.
Phan IQ; Rice CA; Craig J; Noorai RE; McDonald JR; Subramanian S; Tillery L; Barrett LK; Shankar V; Morris JC; Van Voorhis WC; Kyle DE; Myler PJ
Sci Rep; 2021 Nov; 11(1):21664. PubMed ID: 34737367
[TBL] [Abstract][Full Text] [Related]
18. Synthetic nanoparticle-conjugated bisindoles and hydrazinyl arylthiazole as novel antiamoebic agents against brain-eating amoebae.
Kanwal ; Mungroo MR; Anwar A; Ali F; Khan S; Abdullah MA; Siddiqui R; Khan KM; Khan NA
Exp Parasitol; 2020 Nov; 218():107979. PubMed ID: 32866583
[TBL] [Abstract][Full Text] [Related]
19. Anti-Balamuthia mandrillaris and anti-Naegleria fowleri effects of drugs conjugated with various nanostructures.
Siddiqui R; Boghossian A; Alqassim SS; Kawish M; Gul J; Jabri T; Shah MR; Khan NA
Arch Microbiol; 2023 Apr; 205(5):170. PubMed ID: 37017767
[TBL] [Abstract][Full Text] [Related]
20. Innovative Methodology in the Discovery of Novel Drug Targets in the Free-Living Amoebae.
Baig AM
Curr Drug Targets; 2019; 20(1):60-69. PubMed ID: 29697029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
